53 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
.
Each 3-patch package represents one 28-day cycle of therapy. Total Cycles Dispensed represents every cycle dispensed from both retail and non-retail
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
are defined as follows: Twirla cycles dispensed are the number of 3-patch packages dispensed.
Each 3-patch package represents one 28-day cycle
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
9 Nov 23
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:15am
-patch package represents one 28-day cycle of therapy. Total Cycles Dispensed represents every cycle dispensed from both retail and non-retail channels
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
, and/or administration.
(b)Report Templates. The Veeva template field reporting package is designed to drive sales behavior in the following ways:
(1
8-K
EX-99.1
z97jzevd l64c1r
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
qlkz6ne qsna9
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
4cr1075 q2wokq7bqt2
28 Apr 23
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
4:40pm
8-K
EX-99.1
2gc 0iddk2rjzjww68
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
fql9ub2x
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
flnkb5g qc9
13 Jul 22
Agile Therapeutics Updates Second Quarter 2022 Guidance
5:20pm
CORRESP
83lqsf7
29 Jun 22
Correspondence with SEC
12:00am
8-K
EX-99.1
p0ik8p3sb3fi1c
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B5
mr1v1uhwe8yr8eurm4e
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-99.1
tcn3omt6eswic
14 Apr 22
Regulation FD Disclosure
4:15pm
8-K
EX-1.1
vwf8klnglod1ky2zb
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-99.1
ejl4j ibyou1m422nw
10 Sep 21
Regulation FD Disclosure
4:31pm